Multi-Omic Cell Biopsy Platform

About 1Cell.Ai

1Cell.Ai is a San Francisco-based diagnostics company founded in 2020, focused on revolutionizing precision oncology through an AI-powered single-cell multi-omics platform. The company's technology integrates live CTC and ctDNA analysis, AI-driven digital pathology, and a scalable data ecosystem to deliver actionable insights for therapy decisions, clinical trials, and drug development. Targeting clinicians, pharmaceutical companies, and researchers, 1Cell.Ai positions itself at the intersection of cutting-edge molecular science and machine learning to address tumor heterogeneity and improve cancer patient outcomes.

Therapeutic Areas